Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension

被引:13
|
作者
Zhang, Duan-zhen [1 ]
Zhu, Xian-yang [1 ]
Meng, Jing [1 ]
Xue, Hong-mei [1 ]
Sheng, Xiao-tang [1 ]
Han, Xiu-min [1 ]
Cui, Chun-Sheng [1 ]
Wang, Qi-guang [1 ]
Zhang, Po [1 ]
机构
[1] Shenyang No Hosp, Dept Congenital Heart Dis, Shenyang 110016, Peoples R China
关键词
Pulmonary arterial hypertension; Vasoreactivity test; Hemodynamics; Congenital heart defect; INHALED NITRIC-OXIDE; AEROSOLIZED ILOPROST; VASODILATOR CAPACITY; VASCULAR-RESISTANCE; DISEASE; CHILDREN; THERAPY; BOSENTAN; GUIDELINES;
D O I
10.1016/j.ijcard.2010.04.093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Detection of pulmonary vasoreactivity is important for the evaluation of patient with pulmonary arterial hypertension (PAH). The present study aimed to investigate the acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects (CHDs) and severe PAH. Patients and methods: From Mar 2007 to Nov 2009, 75 patients with severe PAH secondary to left-to-right shunt CHDs underwent acute vasodilator test using aerosolized iloprost (n=50) or intravenous adenosine (n=25). The hemodynamics were detected and analyzed. Results: Decreased mean pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) were observed in 39 and 43 patients in the iloprost group, and in 16 and 19 patients in the adenosine group, respectively. However, the mean PAP was higher than 40 mm Hg in both groups. No significant difference was observed in the age and baseline hemodynamics between the patients with the decrease of PVR and mean pulmonary-to-aortic pressure (Pp/Ps) ratio greater than 10% and the remaining patients. Adenosine decreased both PAP and systemic arterial pressure significantly, while iloprost inhalation selectively reduced the PAP and increased the oxygen saturation of femoral arterial blood and the pulmonary-to-systemic flow (Qp/Qs) ratio. Compared with adenosine, iloprost caused a more profound decline in the Pp/Ps ratio, PVR and pulmonary-to-systemic vascular resistance ratio, and increase in the Qp/Qs ratio. Conclusions: The acute haemodynamic responses to adenosine and iloprost varied among the patients with CHDs and severe PAH. Different to adenosine, inhaled iloprost exerted selective pulmonary vasodilative effects and was beneficial for pulmonary gas exchange. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:433 / 437
页数:5
相关论文
共 50 条
  • [21] Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
    Lopes, Antonio
    Alnajashi, Khalid
    ANNALS OF THORACIC MEDICINE, 2014, 9 (05) : 21 - 25
  • [22] Nitroglycerin inhalation for acute treatment of pulmonary arterial hypertension in children with congenital heart disease
    Marwali, Eva Miranda
    Rayhan, Muhammad
    Roebiono, Poppy S.
    CARDIOLOGY IN THE YOUNG, 2021, 31 (09) : 1381 - 1385
  • [23] Platelet abnormalities in adults with severe pulmonary arterial hypertension related to congenital heart defects (Eisenmenger syndrome)
    Remkova, Anna
    Simkova, Iveta
    Valkovicova, Tatiana
    Kaldararova, Monika
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (08) : 925 - 929
  • [24] Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects
    Sitbon, O.
    Beghetti, M.
    Petit, J.
    Iserin, L.
    Humbert, M.
    Gressin, V.
    Simonneau, G.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 25 - 31
  • [25] Effects of low doses of aerosolized iloprost combined with tadalafil in treatment of adult congenital heart disease with severe pulmonary arterial hypertension
    Zhang Caojin
    Huang Yigao
    Huang Tao
    Xia Chunli
    Huang Xinsheng
    Zhang Guolin
    Chen Jimei
    Chen Jiyan
    Zhuang Jian
    CHINESE MEDICAL JOURNAL, 2014, 127 (05) : 975 - 977
  • [26] Therapeutic effects of treat and repair strategy in pediatric patients with pulmonary arterial hypertension and simple congenital heart defects
    Wang, Xiaofeng
    Wang, Shilin
    Lu, Zhongyuan
    Wang, Wenlong
    Wang, Xu
    PULMONARY CIRCULATION, 2024, 14 (02)
  • [27] Iloprost for children with pulmonary hypertension after surgery to correct congenital heart disease
    Xu, Zhuoming
    Zhu, Limin
    Liu, Xinrong
    Gong, Xiaolei
    Gattrell, William
    Liu, Jinfen
    PEDIATRIC PULMONOLOGY, 2015, 50 (06) : 588 - 595
  • [28] Long-Term Follow-Up of Pediatric Patients with Severe Postoperative Pulmonary Hypertension After Correction of Congenital Heart Defects
    Lindberg, Lars
    PEDIATRIC CARDIOLOGY, 2022, 43 (04) : 827 - 836
  • [29] Effects of treprostinil on pulmonary arterial hypertension during surgery for congenital heart disease complicated with severe pulmonary arterial hypertension
    Jiang, Huiwen
    Yu, Xiaodan
    Zhang, Lina
    Wang, Minxin
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2021, 69 (02) : 154 - 160
  • [30] Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension
    Pfarr, Nicole
    Fischer, Christine
    Ehlken, Nicola
    Becker-Gruenig, Tabea
    Lopez-Gonzalez, Vanesa
    Gorenflo, Matthias
    Hager, Alfred
    Hinderhofer, Katrin
    Miera, Oliver
    Nagel, Christian
    Schranz, Dietmar
    Gruenig, Ekkehard
    RESPIRATORY RESEARCH, 2013, 14